A discrete, dicopper μ-alkynyl complex, [Cu 2 (μ-η 1:η 1 - C≡C(C 6 H 4 )CH 3 )DPFN]NTf 2 (DPFN = 2,7-bis(fluoro-di(2-pyridyl)methyl)-1,8-naphthyridine; NTf 2 – = N(SO 2 CF 3 ) 2 – ), reacts with p -tolylazide to yield a dicopper complex with a symmetrically bridging 1,2,3-triazolide, [Cu 2 (μ-η 1:η 1 -(1,4-bis(4-tolyl)-1,2,3-triazolide))DPFN]NTf 2 . This transformation exhibits bimolecular reaction kinetics and represents a key step in a proposed, bimetallic mechanism for copper-catalyzed azide–alkyne cycloaddition (CuAAC). The μ-alkynyl and μ-triazolide complexes undergo reversible redox events (by cyclic voltammetry), suggesting that a cycloaddition pathway involving mixed-valence dicopper species might also be possible. Synthesis and characterization of the mixed-valence μ-alkynyl dicopper complex, [Cu 2 (μ-η 1:η 1 - C≡C(C 6 H 4 )CH 3 )DPFN](NTf 2 ) 2, revealed an electronic structure with an unexpected partially delocalized spin, as evidenced by electron paramagnetic resonance spectroscopy. Studies of the mixed-valence μ-alkynyl complex’s reactivity suggest that a mixed-valence pathway is less likely than one involving intermediates with only copper(I).
No takes yet. Share an insight, caveat, or question.
Ziegler et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: